Edesa Biotech’s Strategic Shift: What the New CFO Means for Their Future
Edesa Biotech appoints Peter J. Weiler as the new CFO, effective May 1, 2025, signaling a strategic shift. Weiler brings a robust track record in biotech and pharma, previously leading…